R&D
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Collaborations & Alliances | Industry News | R&D
Servier & Oncodesign Partner for Parkinson's
R&D partnership involves the LRRK2 kinase inhibitors derived from Oncodesign's proprietary Nanocyclix platform, and their potential to act against Parkinson's03.14.19
-
Bio News | Collaborations & Alliances | Formulation Development | Industry News | R&D
Rosa & Co. & Chugai Enter Research Agreement
For Rosa's PhysioPD research services, which will provide Chugai with a competitive research and development advantage across multiple therapeutic areas03.14.19
-
Bio News | Breaking News | Collaborations & Alliances | R&D
AstraZeneca, Seres in Cancer Research Tie-up
Seres to receive $20 million and financial support for research activities03.12.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Numab & Intarcia Enter License Agreement
Intarcia Therapeutics Inc. has executed its option to in-license ND016, being developed for the treatment of autoimmune disorders03.06.19
-
Bio News | Clinical Trials | Industry News | Information Technology | Methods Development | R&D
Almac Group Launches Almac One
Clinical trial supply solution aims to provide a responsive end-to-end process that enhances visibility and accuracy throughout a clinical study03.06.19
-
Bio News | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | R&D
WuXi STA, Ark Biosciences Sign CMC Devt. & Mfg. Deal
The CDMO will provide Ark with integrated services for in process R&D and manufacturing03.06.19
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
PharmOptima & Ophthy-DS Announce Collaboration
To offer pharmaceutical companies a single reliable source for ocular drug discovery, development, safety, and pharmacokinetics02.28.19
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | Laboratory Testing | R&D
AbCellera, Denali Expand Collaboration
Broadens the scope of original June 2018 partnership, and will now discover antibodies as therapies for neurological indications02.28.19
-
Bio News | Facilities | Industry News | Laboratory Testing | R&D
Parker Bioscience Opens New Testing Facility
The SciLog Suite will provide customers ability to test and optimize key unit operations within their production process, and support process development02.26.19
-
Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Industry News | R&D
SAMDI Tech, WuXi Reach Milestone in Partnership
Provides more than one million compounds in its small molecule screening collection, in part through a partnership with WuXi AppTec’s LabNetwork02.26.19
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | R&D
Emergex Secures State-of-the-Art R&D Facility
Hires chief scientific officer to drive development of its vaccines02.22.19
-
Bio News | Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Methods Development | R&D
Insilico & Teva Enter Collaboration
To apply Insilico’s technology for predictive biomanufacturing to create & execute more efficient production processes of Teva’s biopharmaceutical therapeutics02.21.19
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | Laboratory Testing | R&D
Evotec & HZI Parnter for Novel Antibiotics
Research activities will initially be focused on the optimization of cystobactamids02.20.19
-
Analytical Services | Bio News | Collaborations & Alliances | Industry News | Information Technology | R&D
WuXi STA, BioLingus Form Technology Collaboration
WuXi STA will have exclusive access to BioLingus technology for sublingual and buccal delivery in the CDMO sector02.20.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
PPD & HLT Enter Development Agreement
To create data science-driven clinical research solutions in China with the goal of enhancing global drug development02.20.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
Passage Bio Officially Launches
With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases02.15.19
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | Methods Development | R&D
Axovant Announces Formation of Arvelle Therapeutics
Along with the strategic transition of legacy small molecule team into the newly formed company02.15.19
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
AbCellera & Novartis Announce Collaboration
AbCellera to apply technology to advance programs on up to ten targets elected by Novartis02.15.19
-
Bio News | Collaborations & Alliances | Industry News | R&D
CTI BioPharma Receives $10M Milestone from Teva
The payment was triggered by the achievement of sales milestones for TRISENOX (arsenic trioxide)02.11.19
